pd 98059 and sermorelin

pd 98059 has been researched along with sermorelin in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barabutis, N; Schally, AV; Siejka, A1
Badiavas, EV; Block, NL; Cai, R; Cui, T; Jimenez, JJ; Perez, R; Rodriguez-Menocal, L; Schally, AV; Sha, W; Vila Granda, A; Zarandi, M1

Other Studies

2 other study(ies) available for pd 98059 and sermorelin

ArticleYear
Growth hormone releasing hormone induces the expression of nitric oxide synthase.
    Journal of cellular and molecular medicine, 2011, Volume: 15, Issue:5

    Topics: Animals; Calcium-Calmodulin-Dependent Protein Kinases; Cell Line; Cyclooxygenase 2; Flavonoids; Growth Hormone-Releasing Hormone; Humans; Mice; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; NF-kappa B; Nitric Oxide Synthase Type II; Proliferating Cell Nuclear Antigen; Reactive Oxygen Species; Sermorelin

2011
Agonistic analogs of growth hormone releasing hormone (GHRH) promote wound healing by stimulating the proliferation and survival of human dermal fibroblasts through ERK and AKT pathways.
    Oncotarget, 2016, 08-16, Volume: 7, Issue:33

    Topics: Animals; Cell Proliferation; Cell Survival; Cells, Cultured; Dermis; Extracellular Signal-Regulated MAP Kinases; Fibroblasts; Flavonoids; Growth Hormone-Releasing Hormone; Humans; Male; Mice, Inbred C57BL; Phosphorylation; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Sermorelin; Signal Transduction; Wound Healing

2016